|
The ornamental design for a pharmaceutical tablet, as shown and described.
|
Portions of the tablet are shown in broken lines to indicate that those portions form no part of the claimed design.
Liu, Jiping, Parikh, Darshan, Burnside, Scott, Bhat, Sreenivas S.
Patent | Priority | Assignee | Title |
11279745, | Apr 26 2019 | Novo Nordisk A S | Tolerogenic DNA vaccine |
11466278, | Nov 01 2016 | Novo Nordisk A S | Temperature based plasmid regulation system |
D906513, | Mar 19 2019 | Novo Nordisk A S | Pill |
D907760, | Jan 20 2017 | SOCIÉTÉ DES PRODUITS NESTLÉ S A | Orally ingestible tablet |
D947358, | Mar 19 2019 | Novo Nordisk A/S | Pill |
ER3273, |
Patent | Priority | Assignee | Title |
5770225, | Apr 28 1989 | McNeil-PPC, Inc. | Process of preparing a subcoated simulated capsule-like medicament |
5824338, | Aug 19 1996 | L. PERRIGO COMPANY | Caplet and gelatin covering therefor |
6165513, | Jun 11 1997 | Allergan Pharmaceuticals International Limited | Film-coated tablet for improved upper gastrointestinal tract safety |
D301764, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
D302051, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
31133, | |||
D403396, | Nov 28 1996 | Astra Aktiebolag | Tablet |
D408910, | Nov 28 1996 | Astra Aktiebolag | Tablet |
D425614, | Apr 16 1999 | Merck Sharp & Dohme Corp | Tablet |
D430285, | Apr 16 1999 | MERCK & CO , INC | Tablet |
D431076, | Jul 07 1999 | Merck Sharp & Dohme Corp | Tablet |
D434846, | Jul 07 1999 | Merck Sharp & Dohme Corp | Tablet |
D459798, | Mar 26 2001 | AVENTIS PHARMA S A | Pill tablet |
D506544, | Jan 13 2004 | JOHNSON & JOHNSON CONSUMER INC | Medicinal tablet |
D515202, | Jul 19 2004 | Merck Sharp & Dohme Corp | Tablet |
D534646, | Jan 06 2006 | Access Business Group International LLC | Nutritional supplement tablet |
D535021, | Apr 22 2005 | WM WRIGLEY JR COMPANY | Elliptical tablet |
D564086, | May 30 2005 | Takeda Nycomed AS | Tablet |
D671636, | Apr 23 2010 | DAIICHI SANKYO COMPANY, LIMITED | Pharmaceutical tablet |
D735315, | Jun 25 2012 | Amgen Inc | Pharmaceutical tablet |
D741990, | Jul 30 2013 | RB HEALTH US LLC | Tablet |
D754841, | Feb 03 2012 | KENVUE BRANDS LLC | Oral dosage form |
D755949, | Jul 30 2013 | RB HEALTH US LLC | Tablet |
D771236, | Dec 15 2015 | KENVUE BRANDS LLC | Tablet |
D787042, | Apr 28 2015 | Celgene Corporation | Pharmaceutical tablet |
D787043, | Jun 23 2015 | Celgene Corporation | Pharmaceutical tablet |
D813372, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Feb 13 2018 | Celgene Corporation | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |